KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 203 filers reported holding KITE PHARMA INC in Q3 2016. The put-call ratio across all filers is 1.31 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $4,417,000 | +22.3% | 24,567 | -29.5% | 0.01% | +25.0% |
| Q2 2017 | $3,611,000 | +27.9% | 34,833 | -3.1% | 0.00% | 0.0% |
| Q1 2017 | $2,823,000 | +242.6% | 35,965 | +95.7% | 0.00% | +300.0% |
| Q4 2016 | $824,000 | -41.8% | 18,377 | -27.4% | 0.00% | -50.0% |
| Q3 2016 | $1,415,000 | +48.5% | 25,329 | +32.9% | 0.00% | 0.0% |
| Q2 2016 | $953,000 | +26.1% | 19,055 | +15.7% | 0.00% | +100.0% |
| Q1 2016 | $756,000 | +248.4% | 16,474 | +367.3% | 0.00% | – |
| Q4 2015 | $217,000 | – | 3,525 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wildcat Capital Management, LLC | 2,410,034 | $433,348,000 | 77.71% |
| COWEN INC. | 4,200,600 | $755,310,000 | 26.72% |
| Tyrus Capital S.A.M. | 1,314,812 | $236,416,000 | 18.49% |
| OMNI PARTNERS LLP | 661,711 | $118,982,000 | 15.19% |
| FNY Partners Fund LP | 379,510 | $68,239,000 | 11.61% |
| EQUITEC PROPRIETARY MARKETS, LLC | 240,100 | $43,172,000 | 10.15% |
| EQUITEC PROPRIETARY MARKETS, LLC | 227,500 | $40,907,000 | 9.62% |
| GARDNER LEWIS ASSET MANAGEMENT L P | 773,817 | $139,140,000 | 8.89% |
| Quad Capital Management Advisors LLC | 192,537 | $34,620,000 | 7.10% |
| Avoro Capital Advisors LLC | 496,983 | $89,363,000 | 6.93% |